Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News SeaStar Medical Holding Corp ICU

Healthcare Medical Devices
SeaStar Medical Holding Corporation is a commercial-stage medical technology company. The Company is focused on developing extracorporeal therapies to reduce the consequences of hyperinflammation on vital organs. The Company's technologies rely on science to provide life-saving solutions to critically ill patients. The Company develops and commercializes cell-directed extracorporeal therapies... see more

Recent & Breaking News (NDAQ:ICU)

FDA Grants Breakthrough Device Designation to SeaStar Medical's Selective Cytopheretic Device for Cardiorenal Syndrome

GlobeNewswire September 29, 2023

Case Series of Three Critically Ill Children with Acute Kidney Injury Safely Treated with SeaStar Medical's Selective Cytopheretic Device Published in the Journal Blood Purification

GlobeNewswire August 29, 2023

SeaStar Medical to Hold Business Update Conference Call Today at 4:00 p.m. Eastern Time

GlobeNewswire August 22, 2023

SeaStar Medical Reports Second Quarter 2023 Financial Results and Provides a Business Update

GlobeNewswire August 14, 2023

SeaStar Medical to Sponsor the Critical Care Time Podcast Series Covering Vital Medical Issues for Healthcare Professionals Who Care for Critically Ill Patients

GlobeNewswire June 30, 2023

First Patient Enrolled in SeaStar Medical's Pivotal Clinical Trial with the Selective Cytopheretic Device in Adults with Acute Kidney Injury

GlobeNewswire June 20, 2023

SeaStar Medical to Present at the Maxim Group Virtual Healthcare Conference Hosted by M-Vest on June 21, 2023

GlobeNewswire June 14, 2023

SeaStar Medical Reports First Quarter 2023 Financial Results and Provides a Business Update

GlobeNewswire May 15, 2023

SeaStar Medical to Present at the JMP Securities Life Sciences Conference on May 16, 2023

GlobeNewswire May 10, 2023

SeaStar Medical Provides Regulatory Update Related to its HDE Application for Pediatric Selective Cytopheretic Device

GlobeNewswire May 9, 2023

SeaStar Medical Announces Activation of First Clinical Site in Pivotal Trial with Selective Cytopheretic Device in Critically Ill Adults with Acute Kidney Injury

GlobeNewswire April 19, 2023

SeaStar Medical Reports 2022 Financial Results and Provides a Business Update

GlobeNewswire March 30, 2023

SeaStar Medical Holding Corporation Closes Initial $3.3 Million Tranche of $9.8 Million Private Placement

GlobeNewswire March 16, 2023

SeaStar Medical to Present at the Emerging Growth Virtual Conference on March 22, 2023

GlobeNewswire March 15, 2023

SeaStar Medical's Selective Cytopheretic Device to be Featured at the 5th Chronic Kidney Disease Drug Development Summit

GlobeNewswire February 24, 2023

SeaStar Medical Announces Details of the Selective Cytopheretic Device Pivotal Study in Critically ill Adults with Acute Kidney Injury

GlobeNewswire February 15, 2023

SeaStar Medical to Hold Business Update Conference Call on February 15, 2023

GlobeNewswire February 14, 2023

SeaStar Medical Receives FDA Approval to Begin Study with Selective Cytopheretic Device to Reduce Hyperinflammation in Adults with Acute Kidney Injury

GlobeNewswire February 9, 2023

SeaStar Medical to Present at the Virtual Sequire Biotechnology Conference on February 2, 2023

GlobeNewswire January 31, 2023

SeaStar Medical Submits Investigational Device Exemption (IDE) Application to FDA to Study a Novel Therapy to Reduce Hyperinflammation in Adult Acute Kidney Injury Patients

GlobeNewswire January 9, 2023